Anumana
Develops AI enabled electrocardiogram algorithms to detect hidden cardiac conditions.
What they do
Designs AI driven algorithms that analyze standard 12 lead ECGs to detect complex, often asymptomatic cardiac conditions such as low ejection fraction and pulmonary hypertension. Its technology is designed for integration into clinical software used by physicians.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Electrocardiogram analysis AI
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- Cambridge, United States
- Region
- North America
- Founded
- 2021
- Total funding
- $25M raised
Notable investors: Mayo Clinic, nference.